HUMAN RECOMBINANT INTERLEUKIN-1 RECEPTOR ANTAGONIST PREVENTS ADRENOCORTICOTROPIN, BUT NOT INTERLEUKIN-6 RESPONSES TO BACTERIAL-ENDOTOXIN IN RATS

被引:47
|
作者
SCHOTANUS, K [1 ]
TILDERS, FJH [1 ]
BERKENBOSCH, F [1 ]
机构
[1] FREE UNIV AMSTERDAM,FAC MED,NEUROSCI RES INST,DEPT PHARMACOL,VAN DER BOECHORSTR 7,1081 BT AMSTERDAM,NETHERLANDS
关键词
D O I
10.1210/en.133.6.2461
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The present study was designed to analyze the role of endogenous interleukin-1 (IL-1) in the ACTH, corticosterone (CORT), and IL-6 responses of rats to bacterial endotoxin. Recombinant rat IL-1beta (rIL-1beta) when given ip resulted in dose-dependent increases in plasma ACTH, CORT, and IL-6 concentrations. Plasma ACTH and CORT responses could be induced by low rIL-1beta doses that did not elevate plasma IL-6 levels. The half-maximally effective dose of rIL-1beta was less than 0.6 mug/kg for the ACTH and CORT responses and higher than 2.5 mug/kg for the IL-6 response. Time-course studies indicated that plasma ACTH and CORT concentrations were already elevated 30 min after the injection of rIL-1beta (2.5 mug/kg, ip), with peak values after 1-2 h, followed by a subsequent decline. In contrast, plasma IL-6 concentrations became elevated 2 h after the injection of rIL-10. In another set of experiments, the administration of endotoxin resulted in a dose-dependent elevation of the plasma ACTH, CORT, and IL-6 concentrations. The dose-response characteristics for ACTH, CORT, and IL-6 were different. The half-maximally effective dose for the ACTH and CORT, and IL-6 responses were approximately 2.5 mug/kg and more than 10 mug/kg, respectively. Time courses of plasma ACTH, CORT, and IL-6 responses to endotoxin (2.5 mug/kg, ip) were similar, with peak values measured after 2 h. When given alone, the human IL-1 receptor antagonist (IL-1RA; 1 or 2.5 mg/kg, ip) did not affect resting plasma ACTH and CORT concentrations and reduced plasma IL-6 concentrations in one experiment. At a dose of 1 mg/kg, IL-1RA inhibited ACTH and IL-6 responses to rIL-1beta (2.5 mug/kg, ip) by 75% and 90%, respectively. Administration of IL-1RA (2.5 mg/kg, ip) 30 min after endotoxin (2.5 ug/kg, ip) completely prevented the ACTH response and partially inhibited the CORT response, but did not affect the IL-6 response measured 2.5 h after endotoxin administration. We conclude that 1) IL-1 receptors are involved in the ACTH and IL-6 responses to rat IL-1beta; 2) the ACTH response, but not the IL-6 response, to a low dose dose of endotoxin in rats requires IL-1 receptor activation by endogenous produced IL-1; and 3) circulating IL-6 is not a prime mediator involved in ACTH and CORT responses to low doses of rIL-1beta and endotoxin.
引用
收藏
页码:2461 / 2468
页数:8
相关论文
共 50 条
  • [21] EFFECTS OF PHYSICAL-TRAINING ON FEBRILE AND ACUTE-PHASE RESPONSES INDUCED IN RATS BY BACTERIAL-ENDOTOXIN OR INTERLEUKIN-1
    WADA, M
    MORIMOTO, A
    WATANABE, T
    SAKATA, Y
    MURAKAMI, N
    JOURNAL OF PHYSIOLOGY-LONDON, 1990, 430 : 595 - 603
  • [22] Cord blood concentrations of interleukin-1 receptor antagonist and interleukin-6 and birth order in twins
    Sharma, G
    Nguyen, D
    Vardhana, S
    Rosenberg, VA
    Kalish, RB
    Witkin, SS
    OBSTETRICS AND GYNECOLOGY, 2004, 103 (04): : 72S - 72S
  • [23] DEVELOPMENT OF A HUMAN INTERLEUKIN-6 RECEPTOR ANTAGONIST
    BRAKENHOFF, JPJ
    DEHON, FD
    FONTAINE, V
    TENBOEKEL, E
    SCHOOLTINK, H
    ROSEJOHN, S
    HEINRICH, PC
    CONTENT, J
    AARDEN, LA
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1994, 269 (01) : 86 - 93
  • [24] Treatment of rheumatoid arthritis with recombinant human interleukin-1 receptor antagonist
    Bresnihan, B
    Alvaro-Gracia, JM
    Cobby, M
    Doherty, M
    Domljan, Z
    Emery, P
    Nuki, G
    Pavelka, K
    Rau, R
    Rozman, B
    Watt, I
    Williams, B
    Aitchison, R
    McCabe, D
    Musikic, P
    ARTHRITIS AND RHEUMATISM, 1998, 41 (12): : 2196 - 2204
  • [26] Investigation on PEGylation strategy of recombinant human interleukin-1 receptor antagonist
    Yu, Pengzhan
    Zheng, Chunyang
    Chen, Jing
    Zhang, Guifeng
    Liu, Yongdong
    Suo, Xiaoyan
    Zhang, Guicai
    Su, Zhiguo
    BIOORGANIC & MEDICINAL CHEMISTRY, 2007, 15 (16) : 5396 - 5405
  • [27] SOLUBLE CD23 POTENTIATES INTERLEUKIN-1-INDUCED SECRETION OF INTERLEUKIN-6 AND INTERLEUKIN-1 RECEPTOR ANTAGONIST BY HUMAN MONOCYTES
    HERBELIN, A
    ELHADAD, S
    OUAAZ, F
    DEGROOTE, D
    DESCAMPSLATSCHA, B
    EUROPEAN JOURNAL OF IMMUNOLOGY, 1994, 24 (08) : 1869 - 1873
  • [28] Intracerebroventricular injection of interleukin-1 stimulates the release of high levels of interleukin-6 and interleukin-1 receptor antagonist into peripheral blood in the primate
    Xiao, EN
    Xia, LN
    Ferin, M
    Wardlaw, SL
    JOURNAL OF NEUROIMMUNOLOGY, 1999, 97 (1-2) : 70 - 76
  • [29] Transcriptional regulation of oxytocin receptor by interleukin-1β and interleukin-6
    Schmid, B
    Wong, S
    Mitchell, BF
    ENDOCRINOLOGY, 2001, 142 (04) : 1380 - 1385
  • [30] Induction of interleukin-1 and interleukin-1 receptor antagonist
    Dinarello, CA
    SEMINARS IN ONCOLOGY, 1997, 24 (03) : 981 - 993